Navigation Links
Novel Mechanism for Long-Term Learning Identified by Carnegie Mellon Researchers
Date:1/3/2008

Mechanism Described in Jan. 4 Issue of Science Explains How Neuronal

Connections Continue To Strengthen After Repeated Stimulation

PITTSBURGH, Jan. 3 /PRNewswire/ -- Practice makes perfect -- or at least that's what we're told as we struggle through endless rounds of multiplication tables, goal kicks and piano scales -- and it seems, based on the personal experience of many, to be true. That's why neuroscientists have been perplexed by data showing that at the level of individual synapses, or connections between neurons, increased, repetitive stimulation might actually reverse early gains in synaptic strength. Now, neuroscientists from Carnegie Mellon University and the Max Planck Institute have discovered the mechanism that resolves this apparent paradox. The findings are published in the Jan. 4 issue of Science.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020422/CMULOGO)

The mechanism further explains how brain synapses strengthen in response to new experiences. Previous research by Carnegie Mellon researcher and lead author of the study Alison Barth has shown that there is a connection between synaptic plasticity, or changes, and learning and memory. However, little was known about the mechanisms that underlie learning that occurs over longer timeframes, with continuing training or practice.

Scientists have shown that N-methyl-D-aspartate (NMDA) receptors are required to initiate synaptic plasticity in this mechanism, a fact that holds true in many areas of the brain. Indeed, it is becoming increasingly clear that these receptors are required for the kind of synaptic strengthening that occurs during learning.

Barth and colleagues discovered that the NMDA receptors undergo a sort of Jekyll-and-Hyde transition after an initial phase of learning. Instead of helping synapses get stronger, they actually begin to weaken the synapses and i
'/>"/>

SOURCE Carnegie Mellon University
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ba, Nov. 6 With his proposed healt... his sights on cutting name-brand prescription dru...ll into the "Part D" coverage gap, universally kno...the potential cost-cutting and feel it,s a promisi...st powerful lobbyists want a revised program that ...
(Date:11/6/2009)...E PARK, N.C., Nov. 6 Chimerix, Inc...ailable antiviral therapeutics to address life-thr...pment of the company,s lead antiviral compound, CM...he Global Health Security Initiative (GHSI). CMX0...oped for the treatment of smallpox, as well as oth...
(Date:11/6/2009)...6 NexBio Inc., in collaboration wi...nd Prevention (CDC), St. Louis University, and the...ication of two articles in the peer-reviewed journ...that DAS181 (Fludase ® ) may play a potential... of the Pandemic Influenza A(H1N1) and drug-resist...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4New Surgery Institute at Children 26apos 3Bs National Medical Center Aims to Improve Surgery and Eliminate Pain 57400 1New Surgery Institute at Children 26apos 3Bs National Medical Center Aims to Improve Surgery and Eliminate Pain 57400 2New Surgery Institute at Children 26apos 3Bs National Medical Center Aims to Improve Surgery and Eliminate Pain 57400 3New Surgery Institute at Children 26apos 3Bs National Medical Center Aims to Improve Surgery and Eliminate Pain 57400 4Pennsylvania Patient Safety Authority Releases September Advisory 57396 1Pennsylvania Patient Safety Authority Releases September Advisory 57396 2Pennsylvania Patient Safety Authority Releases September Advisory 57396 3Pennsylvania Patient Safety Authority Releases September Advisory 57396 4Pennsylvania Patient Safety Authority Releases September Advisory 57396 5livethesource 28TM 29 Hosts Company Launch Event While Supporting The Brent Shapiro Foundations Annual Sober Night Out 57392 1livethesource 28TM 29 Hosts Company Launch Event While Supporting The Brent Shapiro Foundations Annual Sober Night Out 57392 2livethesource 28TM 29 Hosts Company Launch Event While Supporting The Brent Shapiro Foundations Annual Sober Night Out 57392 3
...ings from an Otsuka Pharmaceutical Co, Ltd. Sponso...sociation Annual Meeting -, SAN DIEGO, May 23, 200...ts (13- 17 years old) with schizophrenia, the Otsu...bb Company atypical,antipsychotic aripiprazole dem...ebo on the primary efficacy endpoint, Positive and...
...eren (Zurich), Switzerland, May 24, 2007 - Cytos,B...from a,placebo-controlled, double-blind combined p...e candidate for the treatment of,psoriasis and oth...a first-time-in-man clinical trial and included 48... psoriasis. In a first part,of the study, the safe...
Other Medicine Technology:Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 2Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 3Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 4
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ... press conference following the House passage of H...ct. The bill passed by a vote of 220 to 215. Bel...d some of my colleagues just received a call from ...congratulating us on a great victory for the Ameri...
(Date:11/8/2009)... Men’s Health Network...r health risks, especially those linked to exposur...om military service. Bladder cancer is one of thos...rans, especially those who once smoked or currentl...hington DC (PRWEB) November 8, 2009 -- Men’s...
(Date:11/8/2009)..., WASHINGTON, Nov. 7 ...able Health Care for America Act, which will make ...surance companies accountable and increase access ... public option. ,, "Teddy Roosevelt, FDR and Ha...Director Alan Charney. "Today,s vote ranks among o...
(Date:11/8/2009)..., Health Care Vote Shows Who Sides With Working...G, Pa., Nov. 8 On the h...f Representatives for a good, balanced health care...s scoring of how our state,s U.S. representatives ...merica Act. ,, The legislation, which passed S...
(Date:11/7/2009)..., HOUSTON, Nov. 7, Th... its 2009 Benjamin Rush Award for Citizenship and ...halmologist from Chicago, IL. The award recognizes...rofessional call of duty to make an outstanding pu.... Dr. Kraff received the award today during the op...
Breaking Medicine News(10 mins):Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
...nya in three districts of Akola, Buldhana and Wash... While four patients died in Akot, two and one exp.... Many others were believed to have been suffering...lood samples of the affected people have been sent...
...'s planning association all worked up. With the fe...ildren per woman//, demographers are pressing the ...uisite population. A survey conducted by th...n attributed to this abstinence from sex. And near...
... could help to tackle one of Africa's major challe...lized software.// Africa@home, a project con...cherche Nucléaire - the European Organisation for ...the software runs in the background of an idling c...
...follow a career in general practice, according to ... Australia.// Dr Catherine Joyce, Senior Lec...tive Medicine at Monash University and co-author o...red career choices of four cohorts of medical grad...
...ounds being spent on hospitals for the NHS will no...f care.// The report has claimed that the NH...tals that would take 30 years to pay off, when the...t of Health has brought capital investment of all ...
...up to private health insurance to avoid tax or fin... less likely// to be admitted to hospital as priva...on claims that an increase in the number of people...e is a blunt instrument, relying on the notion tha...
Other Medicine News:Health News:Africa Set to Control Malaria Using Specialized Software 2Health News:Health Care Costs Unaffected by Rebate 2
Sugita Aneurysm Clip Bent (M)
Sugita Aneurysm Clip Bent (S)
Sugita Aneurysm Clip J-Shaped (M)
Sugita Aneurysm Clip 1/4 Cvd.
Medicine Products: